Transdermal device containing...

Details Transdermal device containing... Transdermal device containing...

A - Human Necessities

61

K

A61K 31/135 (2006.01) A61K 9/70 (2006.01)

Patent

CA 2172605

The present invention relates to a method of treatment for Alzheimer's disease in a patient in need thereof comprising transdermally administrating to said patient a therapeutically effective amount of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine or a pharmaceutically acceptable salt thereof. Also provided is a transdermal device for administration of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine or a pharmaceutically acceptable salt thereof.

L'invention concerne un procédé de traitement de la maladie d'Alzheimer chez un individu consistant à administrer par voie transdermique audit individu une dose thérapeutiquement efficace de (E)-2-(p-fluorophénéthyle)-3-fluoroallylamine ou d'un de ses sels acceptable pharmaceutiquement. Elle concerne également un dispositif transdermique servant à administrer la (E)-2-(p-fluorophénéthyle)-3-fluoroallylamine ou un de ses sels acceptable pharmaceutiquement.

Affiliated with

Also associated with

Rating

Transdermal device containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal device containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal device containing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1843546